 | ||
| Get Ready for Tuesday Morning Zacks Member, Pent-up demand released by wave after wave of marijuana legalization has created a historic opportunity for investors. With Mexico pushing to legalize nationwide by October, another big boom could be in the making. Worldwide demand has seen heights of $9 billion in 2017 to an expected $32 billion in 2020. By 2025, it could reach $146 billion or even more. That's why I immersed myself in the business aspects of medicinal and recreational cannabis and closely track legislation – both current and pending. We tap the vast profit potential of legal marijuana with an approach that is aggressive but also responsible and vigilant. Tuesday morning, I'll post a new stock that could bring extraordinary gains: This little-known biopharmaceutical company recently announced positive results on tests of a breakthrough new drug candidate that could add $500 million in annual top-line sales. Demand for this new drug could send profits skyrocketing. Right now, you can be first in line to see it, and also immediately access live picks that are already in the portfolio. Important: To make profiting more convenient, we are limiting the number of investors who will share them. The portfolio has briefly re-opened but will close again to public entry midnight Sunday, September 1 – tonight. Good Investing,
| ||
 | ||
| This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through August 5, 2019. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed above. Zacks Emails Zacks Investment Research |
没有评论:
发表评论